author-photo

Timothy J. Perren

St James's University Hospital

192

Papers

9341

Citations

Citation Trend

Filter By

Papers (141) Sort By

Journal Conference Others

Abstract PD1-11: Mature survival update of the double-blind placebo-controlled randomised phase II PAKT trial of first-line capivasertib plus paclitaxel for metastatic triple-negative breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Quality of Life with weekly platinum-based chemotherapy in newly diagnosed Ovarian Cancer: the ICON8 phase III randomised controlled clinical trial

2020 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P2-16-15: 10-year outcome for women randomized in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: An anglo-celtic cooperative oncology group study

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
805O ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatment

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
815MO The impact of chemosensitivity assessed by modeled CA-125 KELIM on the likelihood of long progression-free survivorship (PS) after 1st line treatment in ovarian cancer: An analysis of 4,450 patients

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre.

2020 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (7)
Neoadjuvant Chemotherapy Versus Debulking Surgery in Advanced Tubo-Ovarian Cancers: Pooled Analysis of Individual Patient Data From the EORTC 55971 and CHORUS Trials

2019 Obstetrical & Gynecological Survey
Show All
- Source
- Cite
- Save
Citations (26)
High EMSY expression defines a BRCA‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum

2019 Cancer
Show All
- Source
- Cite
- Save
Citations (17)
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor

2019 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (26)